4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-054825
EVP, CBO, GC & Secretary sold 39,271 shares at an average $16.86 ($661,969)
- EVP, CBO, GC & Secretary acquired 39,271 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Primiano Christopher Brett · EVP, CBO, GC & Secretary
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-13 | Exercise or conversion : show line 1 in the form | +38,550 | $9.21 | $355,046 | 43,199 | D |
| 2020-10-13 | Sale : show line 2 in the form | −38,550 | $16.85 | $649,568 | 4,649 | D |
| 2020-10-13 | Exercise or conversion : show line 3 in the form | +721 | $10.39 | $7,491 | 5,370 | D |
| 2020-10-13 | Sale : show line 4 in the form | −721 | $17.20 | $12,401 | 4,649 | D |
| Open-market sales · 39,271 sh · avg $16.86 · $661,969 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-10-13 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −38,550 | $9.21 | 2029-02-14 | 38,550 | 64,250 | D |
| 2020-10-13 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −721 | $10.39 | 2027-01-19 | 721 | 75,779 | D |
Loading xslF345X03/doc4.xml…